{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:59:24Z","timestamp":1781373564843,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005792","name":"University System of Taiwan","doi-asserted-by":"publisher","award":["VGHUST113-G4-3-1"],"award-info":[{"award-number":["VGHUST113-G4-3-1"]}],"id":[{"id":"10.13039\/501100005792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.151957","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:56:23Z","timestamp":1775897783000},"page":"151957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Asialoglycoprotein receptor-bound PLGA nanoparticles loaded with Riociguat targetedly ameliorate portal hypertension in liver cirrhosis"],"prefix":"10.1016","volume":"360","author":[{"given":"Shao-Jung","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chiung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Lung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Fan","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151957_bb0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221101712","article-title":"Management of varices and variceal hemorrhage in liver cirrhosis: a recent update","volume":"15","author":"Diaz-Soto","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"H\u00e4ussinger","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10308","key":"10.1016\/j.ijbiomac.2026.151957_bb0020","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151957_bb0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151957_bb0030","article-title":"Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy","volume":"3","author":"Iwakiri","year":"2021","journal-title":"JHEP Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151957_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcma.2012.11.005","article-title":"Management of ascites in patients with liver cirrhosis: recent evidence and controversies","volume":"76","author":"Hsu","year":"2013","journal-title":"J. Chin. Med. Assoc."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151957_bb0040","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/liv.15559","article-title":"Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension","volume":"43","author":"Turco","year":"2023","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151957_bb0045","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/HEP.0000000000000278","article-title":"Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC","volume":"78","author":"Sharpton","year":"2023","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.151957_bb0050","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.12998\/wjcc.v9.i19.5179","article-title":"Systematic review and meta-analysis of transjugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151957_bb0055","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","article-title":"Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension","volume":"69","author":"Tripathi","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0060","article-title":"Global burden of liver cirrhosis 1990-2019 and 20 years forecast: results from the global burden of disease study 2019","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.chest.2016.05.024","article-title":"Riociguat: mode of action and clinical development in pulmonary hypertension","volume":"151","author":"Ghofrani","year":"2017","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151957_bb0070","doi-asserted-by":"crossref","first-page":"G1311","DOI":"10.1152\/ajpgi.00368.2007","article-title":"Effect of the nitric oxide donor V-PYRRO\/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice","volume":"294","author":"Edwards","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1039\/D4MD00652F","article-title":"Hepatocyte targeting via the asialoglycoprotein receptor","volume":"16","author":"Ram\u00edrez-Cort\u00e9s","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151957_bb0080","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.4049\/jimmunol.167.10.5767","article-title":"Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptormediated endocytosis","volume":"167","author":"Valladeau","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151957_bb0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00705-010-0657-5","article-title":"Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface","volume":"155","author":"Yang","year":"2010","journal-title":"Arch. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151957_bb0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.chembiol.2021.02.024","article-title":"Degradation from the outside in: targeting extracellular and membrane proteins for degradation through the endolysosomal pathway","volume":"28","author":"Ahn","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0095","article-title":"Simplified quantification method for in vivo SPECT\/CT imaging of asialoglycoprotein receptor with (99 m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97808-0","article-title":"Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe","volume":"11","author":"Saraswathy","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151957_bb0105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.20172","article-title":"Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis","volume":"39","author":"Hilgard","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151957_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13317-012-0041-4","article-title":"Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity","volume":"3","author":"Roggenbuck","year":"2012","journal-title":"Auto Immun. Highlights"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10717544.2016.1225856","article-title":"Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma","volume":"24","author":"Pranatharthiharan","year":"2017","journal-title":"Drug Deliv."},{"issue":"48","key":"10.1016\/j.ijbiomac.2026.151957_bb0120","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1002\/chem.202002142","article-title":"Gold-speckled SPION@SiO2 nanoparticles decorated with Thiocarbohydrates for ASGPR1 targeting: towards HCC dual mode imaging potential applications","volume":"26","author":"Siciliano","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/nano10040656","article-title":"Systemic review of biodegradable nanomaterials in nanomedicine","volume":"10","author":"Su","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0130","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.151957_bb0135","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1039\/b702538f","article-title":"Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer","volume":"17","author":"Yang","year":"2007","journal-title":"J. Mater. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.22159\/ajpcr.2017.v10i2.15502","article-title":"Method development and validation of ultraviolet-visible spectroscopic method for the estimation of assay of sugammadex sodium, apremilast, riociguat and vorapaxar sulphate drugs in active pharmaceutical ingredient form","volume":"10","author":"Chakravarthy","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151957_bb0145","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.5530\/ijper.53.4s.159","article-title":"Stress degradation studies of riociguat, development of validated stability indicating method, identification, isolation and characterization of degradation products by LC-HR-MS\/MS and NMR studies","volume":"53","author":"Pandya","year":"2019","journal-title":"Indian J. Pharm. Educ. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151957_bb0150","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/hep.27679","article-title":"Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats","volume":"61","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151957_bb0155","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/0016-5085(93)90152-3","article-title":"Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats","volume":"105","author":"Lee","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.25625","article-title":"Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats","volume":"56","author":"Huang","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151957_bb0165","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0016-5085(92)90179-3","article-title":"Vasodilatation and sodium retention in prehepatic portal hypertension","volume":"102","author":"Albillos","year":"1992","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151957_bb0170","first-page":"263","article-title":"Establishment of an animal model of hepatic encephalopathy","volume":"63","author":"Chu","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2017.02.039","article-title":"Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats","volume":"802","author":"Chang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151957_bb0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1039\/D0BM01814G","article-title":"Engineered photochemical therapeutic nanocomposites provide effective antibiofilm and microbicidal activities against bacterial infections in porous devices","volume":"9","author":"Lee","year":"2021","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejps.2009.02.008","article-title":"ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells","volume":"37","author":"Chittasupho","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151957_bb0190","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/bcp.14676","article-title":"Riociguat: clinical research and evolving role in therapy","volume":"87","author":"Klinger","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151957_bb0195","first-page":"1","article-title":"Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system database","volume":"21","author":"Wang","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151957_bb0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0205","first-page":"153","article-title":"Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states","volume":"15","author":"Tran","year":"2022","journal-title":"Am. J. Biomed. Sci. Res."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151957_bb0210","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00015.2005","article-title":"Function of cGMP-dependent protein kinases as revealed by gene deletion","volume":"86","author":"Hofmann","year":"2006","journal-title":"Physiol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2026.151957_bb0220","first-page":"S27","article-title":"Absorption of riociguat (BAY 63-2521): bioavailability, food effects, and dose proportionality","volume":"6","author":"Becker","year":"2016","journal-title":"Pulm. Circ."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.151957_bb0225","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1042\/CS20210602","article-title":"Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats","volume":"135","author":"Huang","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.151957_bb0230","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.3390\/ijms22147662","article-title":"Glycyrrhizin attenuates portal hypertension and collateral shunting via inhibition of extrahepatic angiogenesis in cirrhotic rats","volume":"22","author":"Pun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151957_bb0235","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0168-8278(99)80228-1","article-title":"Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats","volume":"31","author":"Van de Casteele","year":"1999","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151957_bb0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1478-3231.2004.00892.x","article-title":"Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients","volume":"24","author":"Colle","year":"2004","journal-title":"Liver Int."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2026.151957_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12072-017-9826-x","article-title":"Biology of portal hypertension","volume":"12","author":"McConnell","year":"2018","journal-title":"Hepatol. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2026.151957_bb0250","first-page":"S75","article-title":"Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment","volume":"6","author":"Saleh","year":"2016","journal-title":"Pulm. Circ."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151957_bb0255","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters","volume":"10","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026018830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026018830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:33:58Z","timestamp":1777955638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026018830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"alternative-id":["S0141813026018830"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151957","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asialoglycoprotein receptor-bound PLGA nanoparticles loaded with Riociguat targetedly ameliorate portal hypertension in liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151957"}}